FDA postpones plan for new hearing aid sales channel – again

In the US, the option to buy over-the-counter hearing aids has had multiple delays, and from the look of things now, the guidelines for the so-called OTC sales won't be nade public until early 2023 – if then.

Photo: Andrew Kelly/Reuters/Ritzau Scanpix

The farce surrounding the development of a US over-the-counter (OTC) category for the sales of low-cost hearing aids continues.

For some years, hearing aid manufacturers of all sizes and shapes have been waiting with anticipation for the US Food and Drug authority (FDA) to provide the guidelines which will define the contours of how OTC sales of hearing aids will operate in the future.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs